Digital Health commercialization expert, seasoned biopharma refugee
Joined March 2011
- Tweets 188
- Following 98
- Followers 45
- Likes 91
12 Photos and videos
15 Oct 2024
The sound of the ball clanging off the left upright no good is the very definition of the NY Jets
3
172
2 Aug 2024
Check out the new single from @MarinaOsk, Iceland’s finest Jazz vocalist taking a twangy turn to Country. Saw her at the Rekjavik Jazz Fest when she debuted her great album “One Evening in July” and have listened to it 1000 times since then. Enjoy! open.spotify.com/album/7pPw1…
88
6 May 2024
Great news from the APA meeting in NYC! Tremendous response to the first presentation of the Phase 2b study and new data showing the immense #burden of generalized anxiety disorder (aka #GAD). Honored to be here to see the reaction of #psychiatrists to @mindmedco data first-hand.
4 May 2024
We presented long-term follow up data from our Phase 2b study of MM120 in generalized anxiety disorder (GAD) and the burden of undiagnosed GAD at the @APApsychiatric 2024 Annual Meeting. Read press release for details: brnw.ch/21wJsOf #APA2024
1
1
146
12 Mar 2024
When #FDA gives breakthrough therapy designation to a derivative of #LSD for study in people living with #anxiety, that’s when I know we’re not in Kansas anymore, Dorothy. #Kudos to all involved for following the science and overcoming bias and stigma. The unmet need demands it.
11 Mar 2024
Our CMO, Dr. Daniel Karlin was featured in @CNN discussing MindMed’s FDA breakthrough therapy designation for MM120 in GAD and the positive 12-week durability data from our Phase 2b study of MM120 in GAD. Read the full article here: bit.ly/3ItKO9W $MNMD
1
1
79
Michael Seggev retweeted
8 Mar 2024
The impact of whether someone discontinued an SSRI/SNRI or not ('not' being because they were unmedicated in the first place) prior to trial of psilocybin vs escitalopram for depression was huge. Discontinuation muted the difference between the arms. nejm.org/doi/10.1056/NEJMc21…
8
17
91
11,475
7 Mar 2024
Really impressed with the way this leadership team has designed and executed clinical development in this tricky arena. Great to see it paying off and recognized.
#GAD #anxiety #brainhealth
7 Mar 2024
Our Phase 2b trial of MM120 in GAD patients met its key secondary endpoint, demonstrating clinically & statistically significant durability of activity observed through week 12 after a single dose with no additional therapeutic intervention. Read more: brnw.ch/21wHF1f
49
7 Mar 2024
RT @mindmedco: Our Phase 2b trial of MM120 in GAD patients met its key secondary endpoint, demonstrating clinically & statistically signifi…
20
7 Mar 2024
The burden of GAD is so great and under appreciated. I’ve seen in my own family how anxiety can rob someone of their QOL and overwhelm their ability to enjoy life’s blessings. That’s why I’m so hopeful about today’s news from @mindmedco and #proud of their amazing, resilient team
7 Mar 2024
Today, we announced the FDA has granted breakthrough therapy designation for MM120 in GAD. We also announced positive 12-week durability data from our Phase 2b study of MM120 in GAD and are hosting a call at 8AM ET to discuss details. Read more: brnw.ch/21wHEzM $MNMD
45
28 Jul 2023
@HiMyNameIsSeton @dpshow finally getting to Big Deans on a visit to LA in honor of Dan’s impending retirement
1
77
30 Jun 2023
Way to go Professor Hayes! Sorry, couldn’t sail until October…go @J_F_Hayes!
96
6 Jun 2023
After months flying to conventions in San Francisco, San Antonio, Nashville and Chicago (twice), it is a distinct pleasure to “commute” to #bio23 on the ferry from Hingham…welcome to Boston! If you’re here lmk if I can buy you a coffee, meal or drink on @juli_health
5
297
Michael Seggev retweeted
18 Apr 2023
70% of consumers say they'll likely use one or more digital health solutions in the future to improve
their overall health or well being. If that ain't tailwinds, don't know what is...
4
8
31
3,223
16 Apr 2023
See you there @Gil_Bashe 3 times in a row! @juli_health will be in the house sharing new #data and our #secretsauce for #patientengagement
16 Apr 2023
#HIMSS23 is an essential gathering for people seeking to improve and better navigate the (very) fragmented #health ecosystem.
#Digitalhealth and #healthinformation are part of the essential treatment.
See you all soon! @HIMSS #Collaboration
1
3
307
Michael Seggev retweeted
16 Apr 2023
We may be reaching a tipping point for VBC. In the latest UHG earnings call it was reported that Optum serves 4M patients in fully capitated contracts. This number grew by 700K patients in Q1 alone, and is up from 2M at the end of 2021. In large part from MA but good progress.
10
7
61
14,697
22 Mar 2023
40
Michael Seggev retweeted
6 Mar 2023
#ata2023 is a great opportunity to celebrate the massive change this organization has driven in the 30 years they’ve advocated for medical delivery that uses technology and challenges convention to deliver highly effective care. #telehealth #digitalhealth
2
1
62
1 Dec 2022
I spent years working with amazing people living with, educating about and treating HIV/AIDS. I learned so much from these #heroes & remember those lessons every day.
This #worldaidsday I remember Martin, Spencer, Linda, Kiyoshi, Juan, Robert, Linda, Steven, Charles and Bill.
2
15 Nov 2022
What a great first day at #hlth2022 sharing @juli_health with the innovators trying to fix #healthcare. If you’d like to see how #AI driven #chroniccare is done stop by booth 3151-5 and check us out! #digitalhealth #patientempowerment
1
2